Personalised prophylaxis with simoctocog alfa versus standard emicizumab prophylaxis in haemophilia A, a matching-adjusted indirect comparison

被引：0
|
作者：
Kessler, C. M. [1 ]
Corrales-Medina, F. F. [2 ,3 ]
MannuccioMannucci, P. [4 ]
Astermark, J. [5 ,6 ]
Tarantino, M. D. [7 ]
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC USA
[2] Univ Miami, Div Pediat Hematol Oncol, Dept Pediat, Miller Sch Med, Miami, FL USA
[3] Univ Miami, Hemophilia Treatment Ctr, Miami, FL USA
[4] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[5] Lund Univ, Dept Translat Med, Malmo, Sweden
[6] Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Malmo, Sweden
[7] Bleeding & Clotting Disorders Inst, Peoria, IL USA
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO042
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis
    Strand, Vibeke
    McInnes, Iain
    Mease, Philip
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    Choy, Ernest
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 497 - 510
  • [42] Matching-Adjusted Indirect Comparison of Cabozantinib (C) Versus Regorafenib (R) in Advanced Hepatocellular Carcinoma (HCC)
    Venerito, Morino
    Kelley, R. K.
    Mollon, P.
    Blanc, J. F.
    Daniele, B.
    Yau, T.
    Cheng, A. L.
    Valcheva, V.
    Azocar, A. Remiro
    Baio, G.
    Li, Y.
    Abou-Alfa, G. K.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 60 - 60
  • [43] MATCHING-ADJUSTED INDIRECT COMPARISONS OF ANNUALIZED BLEEDING RATE AND TREATMENT UTILIZATION BETWEEN EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII PRODUCTS, BAY 94-9027 AND TUROCTOCOG ALFA PEGOL, FOR PROPHYLAXIS OF SEVERE HAEMOPHILIA A
    Vashi, P.
    Batt, K.
    Klamroth, R.
    Mancuso, M. E.
    Majewska, R.
    Mantovani, L. G.
    VALUE IN HEALTH, 2020, 23 : S690 - S690
  • [44] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Edwards, Christopher J.
    Sawant, Ruta
    Garg, Vishvas
    Du, Ella X.
    Friedman, Alan
    Betts, Keith A.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 167 - 181
  • [45] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Christopher J. Edwards
    Ruta Sawant
    Vishvas Garg
    Ella X. Du
    Alan Friedman
    Keith A. Betts
    Rheumatology and Therapy, 2021, 8 : 167 - 181
  • [46] MATCHING-ADJUSTED INDIRECT COMPARISONS (MAICS) OF EFFICACY AND CONSUMPTION OF BAY 94-9027 VERSUS THREE RECOMBINANT FACTOR VIII (RFVIII) FOR PROPHYLAXIS OF SEVERE HEMOPHILIA A
    Ayyagari, R.
    Deschaseaux, C.
    Vashi, P. B.
    Kessabi, S.
    Gao, W.
    VALUE IN HEALTH, 2018, 21 : S246 - S246
  • [47] MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF RECOMBINANT FACTOR VIII FC AND BAY 94-9027 FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A
    Hakimi, Z.
    Santagostino, E.
    Postma, M.
    Nazir, J.
    VALUE IN HEALTH, 2020, 23 : S742 - S742
  • [48] WORTH THE WEIGHT: EVALUATION OF WEIGHTING STRATEGIES IN UNANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON
    Rasouliyan, L.
    Odom, D.
    VALUE IN HEALTH, 2021, 24 : S189 - S189
  • [49] Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison
    Signorovitch J.
    Swallow E.
    Kantor E.
    Wang X.
    Klimovsky J.
    Haas T.
    Devine B.
    Metrakos P.
    Experimental Hematology & Oncology, 2 (1)
  • [50] A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas
    Jones, R. L.
    Blay, J-Y.
    Lecesne, A.
    Martin-Broto, J.
    Pontes, M. J.
    Fernandez Santos, J. M.
    Garcia San Andres, B.
    Wang, G.
    Wang, S.
    Shin, C. R.
    Maki, R.
    Patel, S.
    Demetri, G. D. S.
    ANNALS OF ONCOLOGY, 2017, 28
12345